Technological advancements improve the objectivity and efficiency of dry eye disease evaluations, enhancing diagnostic accuracy.
2
Noninvasive tear breakup time (NIBUT) is recommended over fluorescein TBUT for diagnosing dry eye disease due to its superior objectivity.
3
Tear osmolarity and inflammatory biomarkers like MMP-9 are critical indicators of dry eye disease, aiding in diagnosis and management.
4
Advanced imaging techniques, including interferometry and meibography, provide detailed insights into tear film stability and meibomian gland health.
5
Artificial intelligence and wearable technologies are emerging tools that promise to enhance the precision and personalization of dry eye disease care.